QUANTIFY study met primary endpoint demonstrating non-inferiority of Ultibro®Breezhaler® vs tiotropium 18 mcg plus formoterol 12 mcg in improving health-related quality of life outcomes[1],[2] ...
Lupin has received the Food and Drug Administration’s permission for Tiotropium Bromide Inhalation Powder, 18 mcg/capsule, which is a generic of Boehringer Ingelheim’s Spiriva HandiHaler. The ...
Lupin is offering Tiotropium Bromide Inhalation Powder, 18 mcg/capsule, for the treatment of chronic obstructive pulmonary disease. Tiotropium Bromide Inhalation Powder, 18 mcg/capsule is a generic ...
Tiotropium powder is supplied in capsules containing tiotropium 18 µg (as tiotropium bromide monohydrate) and lactose monohydrate (as the carrier). [5] Packages containing 6 or 30 capsules with one ...
WISDOM was a 12-month, double-blind, parallel-group, active-controlled study in which all patients received triple therapy (tiotropium 18 mcg once daily, salmeterol 50 mcg twice daily and fluticasone ...
Tiotropium inhalation powder is available as a brand-name drug. It’s not available as a generic drug. Brand name: Spiriva. Tiotropium comes in two forms: inhalation powder and inhalation spray.
Results of two phase III studies show that once-daily Onbrez Breezhaler (indacaterol) plus tiotropium produced a significantly greater improvement in lung function than tiotropium alone in patients ...
Novartis has presented data of once-daily chronic obstructive pulmonary disease (COPD) clinical trial programmes at the European Respiratory Society (ERS) Congress. Overall, Novartis presented 14 ...
Two Phase III studies demonstrated efficacy benefits of combining once-daily Onbrez Breezhaler 150 mcg with tiotropium in patients with COPD[1],[2] INTRUST 1 and 2 studies add to comprehensive data ...
RIDGEFIELD, Conn. & NEW YORK--(BUSINESS WIRE)--A new study, published today in The New England Journal of Medicine (NEJM), showed that SPIRIVA ® HandiHaler ® (tiotropium bromide inhalation powder), a ...
Evaluation of tiotropium efficacy in patients with mild chronic obstructive pulmonary disease (COPD) defined by the 2003 Swedish Society of Respiratory Medicine guidelines (post-bronchodilator FEV 1 ...